Market revenue in 2024 | USD 15.6 million |
Market revenue in 2030 | USD 16.3 million |
Growth rate | 0.7% (CAGR from 2025 to 2030) |
Largest segment | Conventional |
Fastest growing segment | Molecular |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Molecular, Conventional |
Key market players worldwide | BioMerieux SA, Abbott, F. Hoffmann-La Roche Ltd., Siemens Healthineers AG ADR, Becton Dickinson & Co, Qiagen NV, Thermo Fisher Scientific Inc, Meridian Bioscience, Hologic, Inc. |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hospital acquired infections diagnostics market will help companies and investors design strategic landscapes.
Conventional was the largest segment with a revenue share of 55.13% in 2024. Horizon Databook has segmented the Norway hospital acquired infections diagnostics market based on molecular, conventional covering the revenue growth of each sub-segment from 2018 to 2030.
The high prevalence of hospital-acquired infections (HAIs) in Norway has been a significant driver for the growth of the country's HAI control market. According to a survey by the European Centre for Disease Prevention and Control in acute care hospitals – 2022-2023, around 10.45 of the patients admitted to these facilities acquire healthcare-associated infection, which is significantly higher than the EU average of 6.8%.
Multinational corporations maintain a strong foothold due to their innovative diagnostic platforms, extensive R&D investments, and well-established distribution networks.
These players dominate the market with advanced technologies such as PCR-based molecular diagnostics and rapid antigen tests, which are highly valued for their accuracy and speed in detecting HAIs.
Horizon Databook provides a detailed overview of country-level data and insights on the Norway hospital acquired infections diagnostics market , including forecasts for subscribers. This country databook contains high-level insights into Norway hospital acquired infections diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account